Life Science Company News

Reset
Results 421 - 440 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21 22  23  24  25 »

Roche’s subcutaneous OCREVUS one-year data demonstrates near-complete suppression of clinical relapses and brain lesions in patients with progressive and relapsing forms of MS

Read more ››
By: GlobeNewswire - 17 Apr 2024
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche Ltd | Hoffmann-La Roche Ltd. (Edmonton)

Essential Pharma Announces the Acquisition of Reminyl® (galantamine hydrobromide) Oral Capsules

Read more ››
By: GlobeNewswire - 17 Apr 2024
Related companies:  Essential Pharma Ltd

Theolytics successfully closes latest financing raising total of £19M ($24.5M) and welcomes Sound Bioventures as new investor

Read more ››
By: GlobeNewswire - 17 Apr 2024
Related companies:  Theolytics

Nxera Pharma: Notice of Issuance of New Shares Under the Restricted Stock Unit (RSU) Plan and Determination of Payment Amount and Other Matters of Issuance of New Shares Under Previous Years’ RSU Plan

Read more ››
By: GlobeNewswire - 17 Apr 2024
Related companies:  Nxera Pharma Co., Ltd.

BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Brazilian Health Regulatory Agency

Read more ››
By: GlobeNewswire - 17 Apr 2024
Related companies:  BioCryst Pharmaceuticals, Inc.

Enterome Announces Successful Completion of Phase 2 ROSALIE Study of EO2401 in Recurrent Glioblastoma

Read more ››
By: GlobeNewswire - 17 Apr 2024
Related companies:  Enterome S.A.

Medigene to Present at Upcoming Scientific Conferences

Read more ››
By: GlobeNewswire - 17 Apr 2024
Related companies:  Medigene AG

GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO INNOVATIVE INITIATIVES IN ASIA

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024
Related companies:  Gilead Sciences, Inc.

Q1 2024 Revenue and Business Update

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024
Related companies:  Telix Pharmaceuticals Limited

Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment-naïve people with relapsing multiple sclerosis

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024
Related companies:  Novartis Pharmaceuticals Corporation

CS Analytical Continues Capital Investment -Announces Installation of Large-Scale Temperature and Humidity Test Chambers

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024

Prostate Cancer: Advancements in Prevention and Treatment Drive Global Market Growth

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024

Viral Vector and Plasmid DNA Technologies: A Global Market Perspective

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024

75% OF WOMEN AGES 18-59 EXPERIENCED MULTIPLE PELVIC HEALTH ISSUES IN THE PAST YEAR ACCORDING TO A NEW STUDY BY ORIGIN AND IPSOS

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024

SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024
Related companies:  SOPHiA GENETICS SA

Orexo extends patent protection for its nasal epinephrine powder product OX640 in the US

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024
Related companies:  Orexo AB

SyntheticMR and SimonMed Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from SyntheticMR's SyMRI NEURO Software at SimonMed Facilities

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024
Related companies:  SyntheticMR AB

Xeltis Announces Latest Results from aXess Trials to be Presented at 46th Annual Charing Cross Symposium

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024
Related companies:  Xeltis BV

TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering

Read more ››
By: GlobeNewswire - 17 Apr 2024
Related companies:  TScan Therapeutics, Inc.

Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis

Read more ››
By: GlobeNewswire - 17 Apr 2024
Related companies:  Sanofi SA
Results 421 - 440 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21 22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »